Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts Should You Invest in Silver Bullion? June 6, 2025 Trump Admin Strips “Safety” from AI Oversight Institute in Move to Rebrand June 6, 2025 In-fill RC Drilling at Kamperman Confirms High-Grade Gold June 6, 2025